GSK (GSK) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 01/17/24
GSK and AstraZeneca: A leading investment bank gives its verdict with an upgrade and a downgradeProactive Investors • 01/16/24
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must WatchSeeking Alpha • 01/10/24
GSK gets shot in arm from upgrade, AstraZeneca mixed reviews after China dealProactive Investors • 01/03/24